IRF4 and non-small cell lung carcinoma: Mechanistically, Yu et al. [102] discovered that interferon regulatory factor 4 (IRF4) could induce more Th17 cells than Tregs in the malignant pleural effusion of patients with NSCLC via downregulating the expression of HELIOS, one of the dominant genes in Treg cell development.